GEM-BELA-VRd II期试验的最终分析：贝兰他单抗和来那度胺维持2年后，贝兰他单抗+ VRd治疗新诊断的适合移植的骨髓瘤

{"title":"GEM-BELA-VRd II期试验的最终分析：贝兰他单抗和来那度胺维持2年后，贝兰他单抗+ VRd治疗新诊断的适合移植的骨髓瘤","authors":"Verónica González-Calle, Noemi Puig, Enrique Ocio, Javier de la Rubia, Paula Rodríguez-Otero, Borja Puertas, Felipe de Arriba, Valentin Cabañas, Esther Gonzalez Garcia, Cristina Encinas, Alexia Suarez-Cabrera, Joan Bargay, Joaquin Martinez-Lopez, Sonia González-Pérez, Jose Angel Hernandez Rivas, Laura Rosiñol, Beatriz Rey Búa, Miguel Teodoro Hernandez, Rafael Alonso Fernandez, Bruno Paiva, María-Victoria Mateos","doi":"10.1016/S2152-2650(25)03452-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 ","pages":"Pages S32-S33"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Final Analysis of the GEM-BELA-VRd Phase II Trial: Belantamab Mafodotin Plus VRd in Newly Diagnosed Transplant-Eligible Myeloma After 2 Years of Maintenance with Belantamab and Lenalidomide\",\"authors\":\"Verónica González-Calle, Noemi Puig, Enrique Ocio, Javier de la Rubia, Paula Rodríguez-Otero, Borja Puertas, Felipe de Arriba, Valentin Cabañas, Esther Gonzalez Garcia, Cristina Encinas, Alexia Suarez-Cabrera, Joan Bargay, Joaquin Martinez-Lopez, Sonia González-Pérez, Jose Angel Hernandez Rivas, Laura Rosiñol, Beatriz Rey Búa, Miguel Teodoro Hernandez, Rafael Alonso Fernandez, Bruno Paiva, María-Victoria Mateos\",\"doi\":\"10.1016/S2152-2650(25)03452-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10348,\"journal\":{\"name\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"volume\":\"25 \",\"pages\":\"Pages S32-S33\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lymphoma, Myeloma & Leukemia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2152265025034524\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265025034524","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}